STIs
Opinion
Practice guidelines highlights from past year
Based on the most recent Infectious Diseases Society of America guidelines, what would be the preferred therapy for this patient?
Conference Coverage
Can liquid biopsy predict oropharyngeal cancer recurrence?
Latest News
Treatment for BV, trichomoniasis approved for adolescents
Secnidazole can be sprinkled onto applesauce, yogurt, or pudding, and one dose contains a complete treatment course.
News
FDA approves 2-month dosing of injectable HIV drug Cabenuva
“Adults living with HIV have a treatment option that further reduces the frequency of medication,” said Candice Long of Janssen Therapeutics.
From the Journals
One in 12 abandons HIV PrEP prescriptions in U.S., with cost a key barrier
People who received PrEP through a rural provider versus an urban provider were also more likely to abandon PrEP.
Latest News
HIV stigma persists globally, according to Harris poll
Pervasive stereotypes and stigmatization only serve to magnify preexisting social inequities that affect access to appropriate care.
Latest News
Dapivirine vaginal ring for HIV prevention no longer under consideration by the FDA
That leaves cisgender women – especially the Black and Latinx women who make up the vast majority of women who acquire HIV every year – with two...
From the Journals
Clinician experience, life stressors drive HIV adherence, retention in new patients
“Patients who reported better initial experiences with their provider at the first visit were less likely to be lost to follow-up,” said Dr....
From the Journals
HPV testing plus cytology catches two times more cervical lesions
Research suggesets that hrHPV testing is the “best strategy for a timely diagnosis of CIN2+ lesions while avoiding overtreatment” of young women...
Latest News
With sexually transmitted infections off the charts, California pushes at-home tests
Under California’s new law, plans regulated by the state must cover home STI tests when ordered by a health care...
News
FDA approves cabotegravir LA; New HIV PrEP option fills an important gap
“Being able to offer an injectable option is ... a game changer,” said Dr. Lina Rosengren-Hovee of UNC Health.